Kailera Therapeutics (KLRA) AI Analysis
Score
Kailera Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 72/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~217% upside.